Why it Matters
FEMG Holdings is expanding its lobbying efforts in Washington with a new player. They’ve hired Ropes & Gray LLP to tackle health care policy issues, diversifying from just using FrogueClark LLC until now. This move illustrates an aggressive strategy to strengthen influence over Medicare and Medicaid policies.
By the Numbers
FEMG Holdings is new to lobbying, having started only in 2025. For Q2 2025, they reported $30,000 in lobbying expenses with FrogueClark LLC, indicating a potential annual spend of over $120,000. The lobbying team now includes Ropes & Gray LLP and FrogueClark LLC.
Why Now
In early 2025, significant regulatory changes and payment model adjustments in Medicare and Medicaid are underway. Major issues include the Medicare Physician Fee Schedule, Medicare Advantage adjustments, and telehealth reimbursement policies. These developments pose financial and compliance challenges to companies reliant on government health programs.
The Agenda
FEMG Holdings is lobbying on broad health care policies including regulatory compliance, reimbursement policy changes, and health care technology regulations. Key themes are Medicare and Medicaid payment structures, which are currently central congressional priorities.
Competitive Landscape
The competitive landscape in health policy lobbying involves numerous stakeholders. Insurers, health care providers, and tech companies are actively engaged in lobbying activities around the same Medicare and Medicaid policies as FEMG Holdings. The focus on CMS payment policies is competitive owing to its impact across the health sector.
Between The Lines
The firm’s lobbying aligns with critical health policy issues being debated in Congress. Legislative focus is on Medicare and Medicaid modernization, telehealth reimbursement, and price transparency. Committees like the House Energy and Commerce and the Senate Finance Committees are key arenas for these discussions.
The Bottom Line
FEMG Holdings is serious about shaping health care policy, as evidenced by their investment in high-profile lobbying firms. Their focus on Medicare and Medicaid policies underscores their strategic interest in addressing regulatory challenges and financial pressures in the health care sector. As they bolster their presence, their influence in policy matters will likely grow.
< Additionally, learn more about CMS’s initiatives to stay updated on the evolving landscape.
Spot something wrong? Report an issue with this article